Chewy Q3 2025 Earnings Beat, Shares Reverse

Chewy Q3 2025 earnings showed an EPS beat and margin gains, but shares reversed after an initial uptick, creating near-term trading caution.

December 10, 2025·2 min read
View all news articles
Flat centered vector of a pet food bowl with dimming light symbolizing Chewy Q3 2025 earnings reversal and market caution.

KEY TAKEAWAYS

  • Adjusted EPS was $0.32, about 5.4% above consensus.
  • Net sales were $3.12 billion, up 8.3% year-over-year.
  • Shares reversed lower after an initial uptick, signaling investor caution on top-line momentum.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Chewy Inc.'s Q3 2025 earnings showed an EPS beat and margin improvement when the company reported results on Dec. 10, 2025. Shares reversed lower after an initial uptick, underscoring investor caution despite accelerating customer growth.

Quarterly Financial Results

The company said in a press release on Dec. 10, 2025, that it reported Q3 fiscal 2025 results for the quarter ended Nov. 2, 2025. Net sales rose 8.3% year-over-year to $3.12 billion. Adjusted earnings per share (EPS) came in at $0.32, about 5.4% above consensus estimates. Gross margin improved by 50 basis points to 29.8%, reflecting operational efficiencies and product mix enhancements. Free cash flow increased 15.8% year-over-year to $175.8 million, producing a free-cash-flow margin of 5.6%.

Customer Growth and Market Reaction

Active customers grew 4.9% year-over-year to 21.155 million, driven by Autoship subscriptions, which accounted for 83.9% of net sales, up from 80% a year earlier. This recurring revenue helped sustain online market-share gains as Chewy expanded product assortments and technology investments.

Despite the earnings beat, shares initially rose but then reversed lower. The mixed signal of an EPS beat alongside revenue slightly below some consensus estimates tempered the market rally and highlighted investor focus on top-line momentum. The margin expansion and free-cash-flow improvement provide Chewy with flexibility to invest in fulfillment centers, pharmacy and veterinary services, and technology infrastructure—key areas for sustaining recurring revenue growth.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

GE Vernova Stock Climbs After Guidance Upgrade

GE Vernova Stock Climbs After Guidance Upgrade

GE Vernova stock rose after the company raised multi-year targets and boosted dividends and buybacks, pushing traders to price stronger cash-flow outlook.

Designer Brands Earnings Beat Fuels Profit Guidance

Designer Brands Earnings Beat Fuels Profit Guidance

Designer Brands earnings beat and management raised fiscal 2025 adjusted operating income guidance to $50.0-$55.0 million, prompting near-term re-rating.

Cracker Barrel Q1 Results Show Loss and Guidance Cut

Cracker Barrel Q1 Results Show Loss and Guidance Cut

Cracker Barrel Q1 results show a quarterly loss and lower fiscal-2026 targets, a setback that could pressure investor sentiment and share trading.

GameStop Q3 Earnings Miss, Collectibles Surge

GameStop Q3 Earnings Miss, Collectibles Surge

GameStop Q3 earnings showed a revenue miss on Dec. 9, 2025 as collectibles and SG&A cuts delivered EPS, likely prompting share volatility and rebalancing.

Pfizer YaoPharma Deal Brings YP05002 In-House

Pfizer YaoPharma Deal Brings YP05002 In-House

Pfizer YaoPharma deal gives Pfizer exclusive rights to oral GLP-1 candidate, expanding its obesity pipeline and putting traders on clinical milestones.

Fed Rate Cut Dec Tenth Expected

Fed Rate Cut Dec Tenth Expected

Fed Rate Cut Dec Tenth Two Thousand Twenty Five will lower rates while Powell signals a higher bar, leaving traders focused on data gaps and odds.